PRELUDE CAPITAL MANAGEMENT, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$267,000
+2570.0%
44,235
+1910.7%
0.01%
+900.0%
Q2 2017$10,000
-73.7%
2,200
-75.8%
0.00%
-75.0%
Q1 2017$38,000
+58.3%
9,100
+203.3%
0.00%
+33.3%
Q3 2016$24,000
+200.0%
3,000
+20.0%
0.00%
+200.0%
Q1 2014$8,000
-96.1%
2,500
-96.3%
0.00%
-96.9%
Q3 2013$203,000
-80.0%
67,300
-45.9%
0.03%
-85.3%
Q2 2013$1,017,000
-10.2%
124,332
-3.9%
0.22%
+3.3%
Q1 2013$1,132,000129,3320.21%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders